Studies have shown that IPA depends on PXR and AHR receptors to enhance the oxidative and nitrosative stress of breast cancer cells, reduce the proportion of cancer stem cells, enhance anti-tumor immunity, and ultimately inhibit the proliferation and metastasis of cancer cells to improve the survival rate of patients [30]. The gene discussed is NR1I2; the disease is cancer.